939 related articles for article (PubMed ID: 18093111)
1. The efficacy of topical 0.2% hyaluronic acid gel on recurrent oral ulcers: comparison between recurrent aphthous ulcers and the oral ulcers of Behçet's disease.
Lee JH; Jung JY; Bang D
J Eur Acad Dermatol Venereol; 2008 May; 22(5):590-5. PubMed ID: 18093111
[TBL] [Abstract][Full Text] [Related]
2. Relationship between periodontal parameters and Behçet's disease and evaluation of different treatments for oral recurrent aphthous stomatitis.
Arabaci T; Kara C; Ciçek Y
J Periodontal Res; 2009 Dec; 44(6):718-25. PubMed ID: 19076988
[TBL] [Abstract][Full Text] [Related]
3. The efficacy of topical hyaluronic acid in the management of recurrent aphthous ulceration.
Nolan A; Baillie C; Badminton J; Rudralingham M; Seymour RA
J Oral Pathol Med; 2006 Sep; 35(8):461-5. PubMed ID: 16918596
[TBL] [Abstract][Full Text] [Related]
4. Systematic review: the efficacy of topical hyaluronic acid on oral ulcers.
Casale M; Moffa A; Vella P; Rinaldi V; Lopez MA; Grimaldi V; Salvinelli F
J Biol Regul Homeost Agents; 2017 Dec; 31(4 Suppl 2):63-69. PubMed ID: 29202564
[TBL] [Abstract][Full Text] [Related]
5. Topical granulocyte colony-stimulating factor for the treatment of oral and genital ulcers of patients with Behçet's disease.
Bacanli A; Yerebakan Dicle O; Parmaksizoglu B; Yilmaz E; Alpsoy E
J Eur Acad Dermatol Venereol; 2006 Sep; 20(8):931-5. PubMed ID: 16922940
[TBL] [Abstract][Full Text] [Related]
6. The assessment of oral health-related quality of life by factor analysis in patients with Behcet's disease and recurrent aphthous stomatitis.
Mumcu G; Hayran O; Ozalp DO; Inanc N; Yavuz S; Ergun T; Direskeneli H
J Oral Pathol Med; 2007 Mar; 36(3):147-52. PubMed ID: 17305636
[TBL] [Abstract][Full Text] [Related]
7. A composite index for determining the impact of oral ulcer activity in Behcet's disease and recurrent aphthous stomatitis.
Mumcu G; Sur H; Inanc N; Karacayli U; Cimilli H; Sisman N; Ergun T; Direskeneli H
J Oral Pathol Med; 2009 Nov; 38(10):785-91. PubMed ID: 19614861
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the clinical features of recurrent aphthous stomatitis and Behçet's disease.
Oh SH; Han EC; Lee JH; Bang D
Clin Exp Dermatol; 2009 Aug; 34(6):e208-12. PubMed ID: 19549229
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of rebamipide as adjunctive therapy in the treatment of recurrent oral aphthous ulcers in patients with Behçet's disease: a randomised, double-blind, placebo-controlled study.
Matsuda T; Ohno S; Hirohata S; Miyanaga Y; Ujihara H; Inaba G; Nakamura S; Tanaka S; Kogure M; Mizushima Y
Drugs R D; 2003; 4(1):19-28. PubMed ID: 12568631
[TBL] [Abstract][Full Text] [Related]
10. Conjunctival ulcers in Behçet's disease.
Zamir E; Bodaghi B; Tugal-Tutkun I; See RF; Charlotte F; Wang RC; Wechsler B; LeHoang P; Anteby I; Rao NA
Ophthalmology; 2003 Jun; 110(6):1137-41. PubMed ID: 12799237
[TBL] [Abstract][Full Text] [Related]
11. Interferon-alpha treatment of Behçet's disease.
O'Duffy JD; Calamia K; Cohen S; Goronzy JJ; Herman D; Jorizzo J; Weyand C; Matteson E
J Rheumatol; 1998 Oct; 25(10):1938-44. PubMed ID: 9779847
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of the bioadhesive patches containing licorice extract in the management of recurrent aphthous stomatitis.
Moghadamnia AA; Motallebnejad M; Khanian M
Phytother Res; 2009 Feb; 23(2):246-50. PubMed ID: 18853400
[TBL] [Abstract][Full Text] [Related]
13. Low-dose natural human interferon-alpha lozenges in the treatment of Behçet's syndrome.
Kiliç H; Zeytin HE; Korkmaz C; Mat C; Gül A; Coşan F; Dinç A; Simşek I; Süt N; Yazici H
Rheumatology (Oxford); 2009 Nov; 48(11):1388-91. PubMed ID: 19717547
[TBL] [Abstract][Full Text] [Related]
14. Levamisole can modulate the serum tumor necrosis factor-alpha level in patients with recurrent aphthous ulcerations.
Sun A; Wang JT; Chia JS; Chiang CP
J Oral Pathol Med; 2006 Feb; 35(2):111-6. PubMed ID: 16430742
[TBL] [Abstract][Full Text] [Related]
15. [Recurrent aphthous stomatitis: treatment with colchicine. An open trial of 54 cases].
Fontes V; Machet L; Huttenberger B; Lorette G; Vaillant L
Ann Dermatol Venereol; 2002 Dec; 129(12):1365-9. PubMed ID: 12536172
[TBL] [Abstract][Full Text] [Related]
16. Transient benefits for topical hyaluronic acid in recurrent aphthous ulceration.
Porter S
Evid Based Dent; 2007; 8(2):52. PubMed ID: 17589493
[TBL] [Abstract][Full Text] [Related]
17. Irsogladine is effective for recurrent oral ulcers in patients with Behçet's disease : an open-label, single-centre study.
Nanke Y; Kamatani N; Okamoto T; Ogiuchi H; Kotake S
Drugs R D; 2008; 9(6):455-9. PubMed ID: 18989994
[TBL] [Abstract][Full Text] [Related]
18. Lactic acid 5 percent mouthwash is an effective mode of therapy in treatment of recurrent aphthous ulcerations.
Sharquie KE; Al-Tammimy SM; Al-Mashhadani S; Hayani RK; Al-Nuaimy AA
Dermatol Online J; 2006 Dec; 12(7):2. PubMed ID: 17459288
[TBL] [Abstract][Full Text] [Related]
19. Oral health is impaired in Behçet's disease and is associated with disease severity.
Mumcu G; Ergun T; Inanc N; Fresko I; Atalay T; Hayran O; Direskeneli H
Rheumatology (Oxford); 2004 Aug; 43(8):1028-33. PubMed ID: 15161982
[TBL] [Abstract][Full Text] [Related]
20. A double-blind, randomized, saline-controlled study of the efficacy and safety of EUFLEXXA for treatment of painful osteoarthritis of the knee, with an open-label safety extension (the FLEXX trial).
Altman RD; Rosen JE; Bloch DA; Hatoum HT; Korner P
Semin Arthritis Rheum; 2009 Aug; 39(1):1-9. PubMed ID: 19539353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
